Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 11/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | BRAF | P15056 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18307118 | 0.82 | BRAF (0.31) | BRAFCYP1A2POLBCYP3A4CYP2C19 | |
| SCHEMBL3778070 | 0.78 | POLB (0.43) | CA12CA1CA9GAAMAPT | |
| SCHEMBL3778074 | 0.78 | POLB (0.43) | CA12CA1CA9GAAMAPT | |
| SCHEMBL13785800 | 0.78 | POLB (0.43) | CA12CA1CA9GAAMAPT | |
| SCHEMBL4277739 | 0.77 | PAK1 (0.33) | RORCBRAFTP53GAAMAPT | |
| SCHEMBL22416655 | 0.74 | CA12 (0.39) | CA12CA1CA9GAAMAPT | |
| SCHEMBL13062960 | 0.72 | CYP17A1 (0.40) | TP53MAPTSMN1; SMN2POLB | |
| SCHEMBL3777965 | 0.72 | CYP17A1 (0.40) | TP53MAPTSMN1; SMN2POLB | |
| SCHEMBL3777963 | 0.72 | CYP17A1 (0.40) | TP53MAPTSMN1; SMN2POLB | |
| SCHEMBL10092627 | 0.72 | CYP17A1 (0.48) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9624229-B2 | Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases | RIGEL PHARMACEUTICALS, INC. (US) | 2017-04-18 | — | — | US | disclosed |